Affected PTPN22 proteins cause a loss of control of the immune system, which attacks melanocytes in the skin and contributes to vitiligo (Kummer et al., 2007), which is clearly elevated in vitiligo patients (Tu et al., 2003)
, 16 ,
reported that H5N1 IAV infection in lung epithelial cells (A549 cells) decreased Cu/Zn superoxide dismutase (SOD1) expression, which could enhance ROS production, viral replication, and the inflammatory response 27
Healthier skin
Choose injectable BPC-157 if: Your target is a tendon, ligament, joint, or muscle injury You need systemic anti-inflammatory or tissue repair effects Speed and reliability of delivery matter You are working within a structured peptide therapy protocol with a licensed provider Choose oral BPC-157 if: Your primary concern is gut health leaky gut, IBD, IBS, gastric ulcers You want high local GI concentrations, not systemic distribution You prefer non-invasive administration for long-term or maintenance use You are combining BPC-157 with another systemic peptide therapy Consider nasal delivery only if: Neurological applications are the clinical focus A licensed provider explicitly recommends it based on your presentation Injection is contraindicated and oral delivery is insufficient Do not choose a delivery method based on convenience alone
